About this trial
Obsessive-compulsive disorder (OCD) is associated with substantial impairments in quality of life and is among the most disabling psychiatric disorders. Exposure therapy is among the first-line of treatments for obsessive-compulsive disorder (OCD) . Extinction learning is thought to be a core mechanism of therapeutic exposure. Fear and safety signal learning are traditionally associated with activity and connectivity within the canonical corticolimbic "fear circuit", which includes the amygdala, medial prefrontal cortex (mPFC), and hippocampus. Transcranial direct current stimulation (tDCS) is a neuromodulation technology that can augment brain plasticity, learning, and memory. The proposed study will test if obsessive-compulsive disorder (OCD) is associated with inhibitory safety learning deficits and if transcranial direct current stimulation (tDCS) normalizes functional connectivity and safety signal processing to recover extinction deficits in obsessive-compulsive disorder (OCD).
Eligibility criteria
Qualifiers
18 years of age or older
speak English fluently, and
able to provide written and verbal informed consent.
meet criteria for OCD as determined by structured clinical interview
Disqualifiers
active severe substance use disorder(s)
acute suicidality
history of bipolar or psychotic disorder(s)
significant developmental disabilities
Trial design
Treatments tested in this trial
- Active transcranial direct current stimulation
- Sham transcranial direct current stimulation
Treatment groups
Sponsors and collaborators
Yale University
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator